Kwami Ketosugbo

2PUBLICATIONS
35CO-AUTHORS
Environmental epidemiologyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 05, 2026
Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial.

|Apr 23, 2024
Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways.

Mario E Lacouture, Elena Goleva, Neil Shah

Pageof 1